Table 2 The top 15 significant pathways enriched in LAM-LECs (T).
Pathway | p value |
|---|---|
Focal adhesion | < 1.00 × 10–10 |
PI3K-AKT signaling pathway | < 1.00 × 10–10 |
Myometrial relaxation and contraction pathways | < 1.00 × 10–10 |
Vitamin D receptor pathway | < 1.00 × 10–10 |
Focal adhesion–PI3K–AKT–mTOR-signaling pathway | < 1.00 × 10–10 |
Spinal cord injury | 3.01 × 10–10 |
Human complement system | 5.74 × 10–10 |
Arrhythmogenic right ventricular cardiomyopathy | 3.98 × 10–9 |
VEGF-A/VEGFR-2 signaling pathway | 9.36 × 10–9 |
MAPK signaling pathway | 2.52 × 10–8 |
Hippo-Merlin signaling dysregulation | 5.91 × 10–8 |
Nuclear receptors meta-pathway | 7.85 × 10–8 |
Complement and coagulation cascades | 2.37 × 10–7 |
Hair follicle development cytodifferentiation | 2.93 × 10–7 |
miRNA targets in ECM and membrane receptors | 7.94 × 10–7 |
